Autonomous AI in action
Tackling NHS backlogs and improving patient outcomes in dermatology at Chelsea and Westminster Hospital NHS Foundation Trust
Webinar speakers
Dr Keith Grimes
Digital Health Consultant & Innovation Consultant at Curistica Ltd
Dr Lucy Thomas
NHS Consultant Dermatologist at Chelsea and Westminster Hospital NHS Foundation Trust
Plus, Chief Investigator & Clinical Advisory Board Member for Skin Analytics
Dr Audrey Menezes
Senior Clinical Safety & Operations Lead at Skin Analytics
& NHS GP
Autonomous AI impact
Modelled on pilot numbers.
total biopsy
Compared to:
26% for AI with review
27% for teledermatology alone
43% for face-to-face
processing time
Compared to:
5 mins for AI with review (for more cases)
10 mins for teledermatology alone
20 mins for face-to-face
discharge rate
Compared to:
49% discharge rate for AI with review
37% discharge rate for teledermatology alone
Our longstanding NHS partner, Chelsea and Westminster Hospital NHS Foundation Trust (CWFT), are now deploying DERM to identify and discharge patients with benign lesions, without review from their dermatology team.
CWFT have led the way for AI in dermatology, forming national conversations, creating guidance, transitioning from pilot to standard practice, and now serving as a blueprint for other healthcare systems across the globe to follow suit.
By deploying DERM autonomously, CWFT will be able to discharge and reassure patients with benign lesions more quickly whilst releasing up to 30% of appointments with consultants for patients with skin cancer and inflammatory skin diseases like eczema and psoriasis.
CWFT first partnered with Skin Analytics in 2022 to implement DERM into the urgent suspected skin cancer (USSC) pathway at Chelsea and Westminster Hospital. From the launch of the initial pilot, the service has assessed over 10,000 patients and has since become standard practice and expanded Trustwide to West Middlesex University Hospital.
